Skip to main content

Cosmos Health Inc.

corporate_fare Company Profile

Cosmos Health Inc.

COSM·NASDAQ·Trade & Services·CIK 0001474167

Cosmos Health Inc., incorporated in 2009 in Nevada, is a diversified, vertically integrated global healthcare group. The company owns proprietary pharmaceutical and nutraceutical brands, manufactures and distributes healthcare products, and engages in research and development of innovative medicines and drug repurposing. It also operates a telehealth platform. Cosmos Health Inc. operates in the healthcare sector, specifically within the Pharmaceutical and Nutraceutical businesses. The company covers several process phases including research and development, manufacturing, marketing, sales, and distribution of products and services. Its operations include generic medicines, nutraceuticals, biocides, medical devices, novel oncology drugs, drug repurposing, and telehealth services. Generic medicines are pharmaceutical and therapeutic equivalents of branded products, marketed under their chemical names, and generally sold at lower prices. The company also operates in the global nutraceuticals market with its own brand. Nutraceuticals are orally consumed products containing at least one dietary ingredient, used for purposes such as immune system defense, energy, stress, and bones and joints.

Cosmos Health Inc. (NASDAQ:COSM) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 87 items for COSM at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-22, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 6 rated 8 or above. Recent SEC coverage for COSM spans 8-K, 10-Q, 4.

Recent high-impact activity:

  • Cosmos Health Guides Q4 U.S. Revenue to ~$15M at 70% Margin, Reaffirms >$90M 2026
  • Cosmos Health Guides Q4 U.S. Revenue to $15M at 70% Gross Margin as Subscriptions Jump 42% in Five Days
  • Cosmos Health Posts Record $54.3M Nine-Month Revenue, Reaffirms $90M+ 2026 Outlook
  • CosmoFarm Hits $60M+ Annualized Revenue, 4.3x Growth; AI and Robotics Pave Path to $100M
  • Cosmos Health's CMO Pipeline Hits $20M Implied Revenue at 90%+ Margins

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$65.27M
Net Income
-$19.14M
Diluted EPS
-$0.63
Op. Cash Flow
-$8.45M
Free Cash Flow
-$8.5M
Gross Profit
$7.9M
Operating Income
-$16.7M
Cash & Equivalents
$715.67K
Debt / Equity
0.00×
Net Margin
-29.3%
Shares Outstanding
41.07M sh
Source: 10-K · filed 2026-04-15 · accession 0001477932-26-002278

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 2,285,010 shares in COSM as of the October 15, 2026 settlement, a 10.7% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On October 30, 2026, 51.8% of COSM volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)2,285,010 shares as of October 15, 2026
Change vs prior period▼ 10.7%
Days to cover1.00 at avg daily volume of 2,929,531
Daily short volume (FINRA facilities)51.8% of 1,470,220 shares on October 30, 2026
5-day average short volume50.7%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Moderate risk

Filing-implied dilution signals for COSM, detected from its recent SEC filings · based on capital-structure filings through 2026-06-06.

ATM program1 shelf registration

New $100M ATM Offering · Extreme Potential Dilution

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with C →
$0.3097 +0.58% today
52-week range · as of 2026-10-22 $0.1616 – $1.07
Market cap
$30.99M
Volume
2.1M (0.6× avg)
3-mo avg 3.4M
Live data · 2026-11-01 09:19 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed COSM - Latest Insights

COSM
Oct 22, 2026, 11:50 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.2739
Real-time Price: $0.3097 info
Change: +$0.0358 (+13%) info
Market Cap: $30.985M info
COSM
Oct 19, 2026, 9:30 AM EDT
Source: ACCESS Newswire
Importance Score:
7
Price at Filing: $0.330
Real-time Price: $0.3097 info
Change: -$0.0203 (-6%) info
Market Cap: $30.985M info
COSM
Oct 07, 2026, 9:30 AM EDT
Source: ACCESS Newswire
Importance Score:
7
Updated Oct 9, 5:03 PM ET — Cosmos Health reported record preliminary nine-month 2026 revenue of $54.3 million, up 19% from $45.6 million in 2025, and reaffirmed its f…
Price at Filing: $0.3256
Real-time Price: $0.3097 info
Change: -$0.0159 (-5%) info
Market Cap: $30.985M info
COSM
Sep 29, 2026, 9:30 AM EDT
Source: ACCESS Newswire
Importance Score:
7
Price at Filing: $0.3927
Real-time Price: $0.3097 info
Change: -$0.083 (-21%) info
Market Cap: $30.985M info
COSM
Sep 28, 2026, 8:00 AM EDT
Source: ACCESS Newswire
Importance Score:
7
Price at Filing: $0.3633
Real-time Price: $0.3097 info
Change: -$0.0536 (-15%) info
Market Cap: $30.985M info
COSM
Sep 15, 2026, 10:30 AM EDT
Source: ACCESS Newswire
Importance Score:
8
Price at Filing: $0.27195
Real-time Price: $0.3097 info
Change: +$0.03775 (+14%) info
Market Cap: $30.985M info
COSM
Sep 11, 2026, 11:10 AM EDT
Source: ACCESS Newswire
Importance Score:
7
Price at Filing: $0.272899
Real-time Price: $0.3097 info
Change: +$0.036801 (+13%) info
Market Cap: $30.985M info
COSM
Sep 09, 2026, 9:30 AM EDT
Source: ACCESS Newswire
Importance Score:
7
Price at Filing: $0.27545
Real-time Price: $0.3097 info
Change: +$0.03425 (+12%) info
Market Cap: $30.985M info
COSM
Aug 28, 2026, 9:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.2333
Real-time Price: $0.3097 info
Change: +$0.0764 (+33%) info
Market Cap: $30.985M info
COSM
Aug 20, 2026, 5:11 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.2175
Real-time Price: $0.3097 info
Change: +$0.0922 (+42%) info
Market Cap: $30.985M info
COSM
Aug 20, 2026, 9:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.2085
Real-time Price: $0.3097 info
Change: +$0.1012 (+49%) info
Market Cap: $30.985M info
COSM
Aug 19, 2026, 9:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.1857
Real-time Price: $0.3097 info
Change: +$0.124 (+67%) info
Market Cap: $30.985M info
COSM
Aug 18, 2026, 4:31 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.2047
Real-time Price: $0.3097 info
Change: +$0.105 (+51%) info
Market Cap: $30.985M info
COSM
Jul 31, 2026, 11:52 AM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $0.210
Real-time Price: $0.3097 info
Change: +$0.0997 (+47%) info
Market Cap: $30.985M info
COSM
Jul 30, 2026, 11:09 AM EDT
Filing Type: 4
Importance Score:
9
Price at Filing: $0.1889
Real-time Price: $0.3097 info
Change: +$0.1208 (+64%) info
Market Cap: $30.985M info
COSM
Jul 17, 2026, 2:56 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $0.24625
Real-time Price: $0.3097 info
Change: +$0.06345 (+26%) info
Market Cap: $30.985M info
COSM
Jul 16, 2026, 4:35 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.2766
Real-time Price: $0.3097 info
Change: +$0.0331 (+12%) info
Market Cap: $30.985M info
COSM
Jul 16, 2026, 1:15 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.2774
Real-time Price: $0.3097 info
Change: +$0.0323 (+12%) info
Market Cap: $30.985M info
COSM
Jul 15, 2026, 2:15 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.291799
Real-time Price: $0.3097 info
Change: +$0.017901 (+6%) info
Market Cap: $30.985M info
COSM
Jul 14, 2026, 2:40 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $0.303699
Real-time Price: $0.3097 info
Change: +$0.006001 (+2%) info
Market Cap: $30.985M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets